NCT02117648View on ClinicalTrials.gov

A Study of LY2835219 in Participants With Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

August 31, 2015

Conditions
NeoplasmNeoplasm Metastasis
Interventions
DRUG

Abemaciclib

Administered orally

DRUG

Clarithromycin

Administered orally

Trial Locations (2)

38119

Accelerated Comm. Oncology Research Network (ACORN), Memphis

38120

The West Clinic, Memphis

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02117648 - A Study of LY2835219 in Participants With Cancer | Biotech Hunter | Biotech Hunter